Release Kinetics of Circulating Muscle-Enriched MicroRNAs in Patients Undergoing Transcoronary Ablation of Septal Hypertrophy

Autor: Christian Troidl, Sebastian Szardien, Holger Nef, Luise Gaede, Matthias Willmer, Christian W. Hamm, Helge Möllmann, Sandra Voss, Christoph Liebetrau, Johannes Rixe, Andreas Rolf, Oliver Dörr
Rok vydání: 2013
Předmět:
Zdroj: Journal of the American College of Cardiology. 62(11):992-998
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2013.05.025
Popis: ObjectivesThis study sought to evaluate exact release kinetics of microRNAs (miRNAs) in acute myocardial infarction (AMI).BackgroundmiRNAs may be useful as novel biomarkers in patients with cardiovascular disease, although it is difficult to establish the detailed release kinetics of miRNAs in patients with AMI.MethodsWe analyzed the release kinetics of circulating cardiac-specific (miR-21, miR-208a) and muscle-enriched (miR-1, miR-133a) miRNAs using the TaqMan polymerase chain reaction in patients with hypertrophic obstructive cardiomyopathy who were undergoing transcoronary ablation of septal hypertrophy (TASH), a procedure mimicking AMI. Consecutive patients (n = 21) undergoing TASH were included. Serum samples were collected prior to and at 15, 30, 45, 60, 75, 90, and 105 min and 2, 4, 8, and 24 h after TASH.ResultsCirculating concentrations of miR-1 were significantly increased (>3-fold; p = 0.01) after 15 min, with a peak after 75 min (>60-fold; p < 0.001). The miR-21 concentrations were not increased at any time point. Concentrations of miR-133a were significantly increased at 15 min (2.9-fold; p < 0.001) and reached a plateau between 75 and 480 min (>50-fold change). The miR-208a concentrations were elevated at 105 min (>2-fold; p = 0.01), without a further increase.ConclusionsmiR-1, miR-133a, and miR-208a were continuously increased during the first 4 h after the induction of MI. In particular, miR-1 and miR-133a were significantly increased at early time points. These results demonstrate the release kinetics of miRNAs, which are helpful for developing their potential use as biomarkers in patients with acute coronary syndromes.
Databáze: OpenAIRE